Evidence map›Paper›PMID 24752680›Full record

ArticleJournal of autism and developmental disorders2014

Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep.

Suzanne E Goldman, Karen W Adkins, M Wade Calcutt, Melissa D Carter, Robert L Goodpaster, Lily Wang, Yaping Shi, Helen J Burgess, David L Hachey, Beth A Malow

Abstract read
In one paragraph

Article in Journal of autism and developmental disorders, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Suzanne E GoldmanDepartments of Neurology and Pediatrics Burry Chair in Cognitive Childhood Development, Sleep Disorders Division, Vanderbilt University Medical Center, 1161 21st Avenue South, Room A-0116, Nashville, TN, 37232-2551, USA.
Karen W Adkins
M Wade Calcutt
Melissa D Carter
Robert L Goodpaster
Lily Wang
Yaping Shi
Helen J Burgess
David L Hachey
Beth A Malow
Vanderbilt University Medical Center · USRush University Medical Center · US

Funding

YOHIMBINE AS A MODEL OF ORTHOSTATIC INTOLERANCEM01RR000095 · NCRR · VANDERBILT UNIVERSITY · PI DRAKE, WONDER P. · 1985 to 2008
$38.3M
THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI DYKENS, ELISABETH MAY · 1985 to 2014
$18.6M
Melatonin for Sleep in Children with Autism: Safety, Tolerability, and DosingR01HD059253 · NICHD · VANDERBILT UNIVERSITY · PI MALOW, BETH A · 2008 to 2009
$873k
NCRR NIH HHS M01 RR000095NCRR NIH HHS M01 RR-00095NICHD NIH HHS HD15052NICHD NIH HHS P30 HD015052NICHD NIH HHS R01 HD059253NICHD NIH HHS R01HD59253
6 · The paper itself

Abstract

Supplemental melatonin has been used to treat sleep onset insomnia in children with autism spectrum disorders (ASD), although the mechanism of action is uncertain. We assessed endogenous and supplemental melatonin profiles in relation to sleep in nine children with ASD. In endogenous samples, maximal melatonin concentration (C(max)) and time to peak concentration (T(max)) were comparable to those previously published in the literature for typically developing children, and dim light melatonin onsets were captured in the majority of children. In treatment samples (supplemental melatonin), melatonin parameters were also comparable to those previously published for typically developing children. Our findings support that children with ASD and insomnia responsive to low dose melatonin treatment have relatively normal profiles of endogenous and supplemental melatonin.

Indexed as

ChildChild Development Disorders, PervasiveChild, PreschoolFemaleHumansMaleMelatoninPolysomnographySleepSleep Initiation and Maintenance DisordersMelatonin

Identifiers

PMID24752680
PMCPMC4372534
OpenAlexW1984563208

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.